Mx Doses
Hypophosphataemia = <0.7mmol/L.
- PO: 1-2 tablets PO4 Sandoz® q8h orally or
- IV: 20mL ampule POTASSIUM-PO4 DILUTED & slow (not EM slow, proper slow) over 3 hrs
Background
Phosphate is an element which is absorbed through our diets. Found in dairy, grains and meats.
Required for many of the processes in the human body:
- Essential constituent of cytoplasm
- Intracellular compounds
- Bone formation
- Neuromuscular functioning
Phosphate is absorbed in the GIT distal to the duodenum (aided by Vit D) and excreted via the kidneys (aided by PTH).
Normal serum levels: 0.8 - 1.3mmol/L.
Major stores of phosphate:
- Bone (85%)
- Intracellular (in soft tissues) (14%)
- Extracellular fluid (1%)
Aetiology hypophosphataemia
↓ GI Absorption
- Alcoholism (commonest)
- Vitamin D deficiency
- Malabsorptive disease
- PO4 binders
- Ca2+
- Al3+ / Mg2+ antacids
- TPN
- Fasting states (anorexia)
↑ renal excretion
- Hyperparathyroidism
- Glycosuria (DKA)
- Osteomalacia (tumour induced)
- Renal tubular acidosis
- Acute tubular necrosis
- HypoMagnesaemia / HypoKalaemia
- Multiple myeloma
- Fanconi syndrome:
- Proximal tubular dysfxn
- Wilson's disease (children)
- Cystinosis (children)
Metabolic conditions
- Resp. alkalosis
- Hungry bone synd.
- DKA
- Starvation refeeding
Other
- Medications
- Anabolic steroids
- Diuretics
- Sever burns
Clinical
Mechanism |
Early signs PO4 1-2mg/dl |
Late signs PO4 <1mg/dl |
| Dysfunctional bone metabolism |
↓ Bone Mineralisation Bone pain |
Rickets (children) Osteomalacia (adults) |
| Intracellular ATP | ↓ Myocardial contractility Proximal muscle weakness Muscle pain ↑RBC rigidity Encephalopathy |
Heart Failure Arrythmias Rhabdomyolysis Haemolysis Seizures/Coma |
| ↓ RBC 2,3 DPG | ↑ affinity of Hb for O2 | Systemic ischaemia Leucocyte & platelet dysfunction |
Investigations
FE PO4-3 = x100
Management ↓PO4
Treat the underlying cause.
Oral
Phosphate-Sandoz® tablets
Each effervescent tablet contains:
- Phosphate – 16mmol, Sodium – 20.4mmol
Dose: 1-2 tablets (in 100mL water) q8h.
Diarrhoea is a common side effect (? ↓ dose).
Intravenous
| Preparation | Sodium Phosphate | Addiphos® |
|---|---|---|
| Contents | Each 20mL ampoule contains:
|
Each 20mL ampoule contains:
|
| Dose | One 20 mL ampoule | 10-20mL of one ampoule |
| Preparation | Dilute 1 ampoule in ≥500mL of NaCl 0.9% or DW5 | Dilute 1 20mL ampoule in 750mL of DW5 |
| Infusion | Administer over at least 2 hours:
|
Admin. over 3 - 12 hours
|
Links
- From CUH Intranet Pharmacy Guideline on Mx ↓PO4-- solution dilutions
Content by: Aoife Delaney, Ciara O'Riordan, Dr Eva Long, Prof Liam Plant Dec 2020
References (from above CUH document)
- Yu ASL, Stubbs JR. Hypophosphatemia: Evaluation and treatment. Last updated: May 22, 2019 (accessed 03/06/2020). Available from www.uptodate.com
- Yu ASL, Stubbs JR. Hypophosphatemia: Clinical manifestations of phosphate depletion. Last updated: Apr 06, 2020 (accessed 03/06/2020). Available from www.uptodate.com
- Yu ASL, Stubbs JR. Hypophosphatemia: Causes of hypophosphatemia. Last updated: Mar 12, 2020 (accessed 03/06/2020). Available from www.uptodate.com
- Summary of Product characteristics for Addiphos. Fresenius Kabi Deutschland GmbH. Last updated: April 09, 2019. (accessed 29/04/2020). Available from www.hpra.ie
- Summary of product characteristics for Phosphate Sandoz. HK Pharma Ltd. Last updated: Oct 29, 2015 (accessed 29/04/20). Available from www.medicines.org.uk
- Summary of product characteristics for Natrium Phosphat (translation). B Braun. Last updated: April 14, 2011 (accessed 29/04/20). Available from B Braun on request
- Martindale 'The Complete Drug Reference': Hypophosphataemia Electrolytes - Phosphate Homoeostasis. Last updated: Jul 10, 2018 (accessed via MedicinesComplete 03/06/2020). Available from www.medicinescomplete.com
- Martindale 'The Complete Drug Reference': Phosphate Uses and Administration. Last updated: Aug 24, 2010 (accessed via MedicinesComplete 03/06/2020). Available from www.medicinescomplete.com